8 completed, 5 unknown. 7 Phase 1, 5 Phase 2, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 6, Unknown 1 |
| Phase 2 | 5 | Completed 3, Unknown 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Unknown 1 |
Follow Shiga University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Night in Japan Home Sleep Monitoring Study Sleep Initiation and Maintenance Disorders, Depression | Unknown | Shiga University | 2000 | 2017-09-06 | 2018-04-20 | |
| Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer S-488410 - Carcinoma, Non-Small-Cell Lung | Phase 2 | Unknown | Shiga University | 45 | 2012-05-01 | 2015-08-13 |
| A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer Aprepitant - Non-small Cell Lung Cancer | Completed | Shiga University | 10 | 2012-04-01 | 2020-09-01 | |
| Shiga Microalbuminuria Reduction Trial-2 Aliskiren, any angiotensin receptor blockers - Type 2 Diabetes Mellitus, Hypertension | Phase 4 | Completed | Shiga University | 237 | 2011-10-01 | 2018-02-19 |
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer HLA-A*2402restricted URLC10, CDCA1, and KIF20A peptides with adjuvant - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Shiga University | 6 | 2011-09-01 | 2019-03-19 |
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer HLA-A*0201restricted URLC10 peptides with adjuvant - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Shiga University | 6 | 2011-08-01 | 2019-03-19 |
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumors HLA-A*2402 or A*0201 restricted peptides - Solid Tumors | Phase 1 / Phase 2 | Completed | Shiga University | 26 | 2010-06-01 | 2019-03-19 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer HLA-A*0201 or HLA-A*0206-restricted URLC10 peptides - Non-small Cell Lung Cancer | Phase 1 | Completed | Shiga University | 9 | 2010-02-01 | 2019-03-19 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer HLA-A*2402-restricted CDCA1 and KIF20A peptides - Small Cell Lung Cancer | Phase 1 | Completed | Shiga University | 9 | 2010-02-01 | 2019-03-19 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer HLA-A*2402restricted URLC10, CDCA1, and KIF20A peptides - Non-Small Cell Lung Cancer | Phase 1 | Completed | Shiga University | 18 | 2010-02-01 | 2019-03-19 |
| The Effect of Sacral Surface Electrical Stimulation for Assisted Reproductive Technology SSE - Infertility | Phase 1 / Phase 2 | Unknown | Shiga University | 100 | 2010-01-01 | 2010-03-09 |
| Shiga Progression of Diabetes, Nephropathy and Retinopathy Pioglitazone add on to SU or biguanide, SU or Biguanide - Type 2 Diabetes Mellitus | Not applicable | Unknown | Shiga University | 400 | 2008-03-01 | 2009-02-19 |
| Rationale and Design for Shiga Microalbuminuria Reduction Trial Valsartan, Amlodipine - Hypertension, Diabetes Mellitus | Phase 4 | Unknown | Shiga University | 160 | 2003-12-01 | 2006-04-27 |
Carcinoma, Non-Small-Cell Lung (6) · Lung Neoplasms (4) · Diabetes Mellitus, Type 2 (3) · Albuminuria (2) · Hypertension (2) · Depression (1) · Diabetes Mellitus (1) · Diabetic Nephropathies (1) · Diabetic Retinopathy (1) · Infertility (1) · Sleep Apnea Syndromes (1) · Sleep Initiation and Maintenance Disorders (1) · Small Cell Lung Carcinoma (1)
NUF2 protein, human (3) · Adjuvants, Pharmaceutic (2) · KIF20A protein, human (2) · LY6K protein, human (2) · Amlodipine (1) · Aprepitant (1) · Biguanides (1) · HLA-A*02:01 antigen (1) · HLA-A*24:02 antigen (1) · Valsartan (1) · aliskiren (1)
Japan (13)
Yataro Daigo, MD, PhD (7) · Atsunori Kashiwagi, PhD. (1) · Atsunori Kashiwagi, Professor (1) · Hiroshi Kadotani, MD,PhD (1) · Hiroshi Maegawa, M.D. (1)